Zenith Health Care Ratios

Zenith Health Care Ltd Ratios

The Zenith Health Care Ltd Ratios page provides a complete fundamental analysis of Zenith Health Care Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Zenith Health Care Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Zenith Health Care Ltd (NSE: , BSE: 530665) is currently trading at ₹3.17, with a market capitalization of ₹170.35M. As a major player in the Health technology sector and Pharmaceuticals: other industry, Zenith Health Care Ltd remains a key stock for fundamental analysis using Zenith Health Care Ltd Ratios.

Zenith Health Care Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Zenith Health Care Ltd P/E ratio currently stands at 334.40, making it one of the most tracked metrics in Zenith Health Care Ltd Ratios.

Historically, the Zenith Health Care Ltd P/E ratio has shown strong fluctuations:

• 2024: 334.40
• 2023: 108.44
• 2022: 274.48
• 2021: 123.36
• 2020: 69.23

The rising Zenith Health Care Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Zenith Health Care Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 3.03.

Historical P/B trend:

• 2024: 3.03
• 2023: 3.01
• 2022: 2.96
• 2021: 5.36

Zenith Health Care Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Zenith Health Care Ltd P/S ratio currently stands at 1.98, an important part of Zenith Health Care Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.98
• 2023: 1.53
• 2022: 1.63
• 2021: 1.70

The rising Zenith Health Care Ltd P/S ratio indicates improved revenue valuation by investors.

Zenith Health Care Ltd Price to Cash Flow Ratio (P/CF)

The Zenith Health Care Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 33.31.

Historical Zenith Health Care Ltd Price to Cash Flow Ratio:

• 2024: 33.31
• 2023: 12.72
• 2022: 0
• 2021: 29.08
• 2020: 0

The rising Zenith Health Care Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Zenith Health Care Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Zenith Health Care Ltd EV currently stands at ₹197.27M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 197.27M
• 2023: 195.41M
• 2022: 204.73M
• 2021: 364.46M

Zenith Health Care Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Zenith Health Care Ltd EV/EBITDA ratio is currently 116.52, a key metric in Zenith Health Care Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 116.52
• 2023: 57.17
• 2022: 150.53
• 2021: 66.96

Higher Zenith Health Care Ltd EV/EBITDA suggests premium valuation.

Zenith Health Care Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Zenith Health Care Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0
• 2023: 0
• 2022: 0
• 2021: 0

Zenith Health Care Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Zenith Health Care Ltd ROE currently stands at 0.91%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 0.91
• 2023: 2.79
• 2022: 1.08
• 2021: 4.44

Declining ROE indicates pressure on profitability.

Zenith Health Care Ltd Ratios Analysis Summary

The Zenith Health Care Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Zenith Health Care Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Zenith Health Care Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.